Physician

Andrew John Sumnicht, MD

According to 2025 Medicare claims, Andrew Sumnicht, MD (NPI: 1306335435) practices ophthalmology in the Mount Vernon-Anacortes, WA market, with the plurality of this provider's patient population coming from Skagit, WA. This provider's primary affiliated billing organization is NORTH CASCADE EYE ASSOCIATES PS (NPI: 1093750481; TIN: 331011052) and primary practice location at 98274-8752.

Sumnicht's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 712 traditional Medicare patients, billed 1,889 HCPCS/CPT codes, and received $173,181 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 1,199 prescription claims across 452 beneficiaries totaling $462,926 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 12 records totaling $399. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,203 to $462,926. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$87K$173K2022 Medicare payment: $41,114 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $156,880 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $173,181 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022137350$41,114
20235511,411$156,880
20247121,889$173,181

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$231K$463K2020 Drug cost: $2,203 (USD; Tot_Drug_Cst)2021 Drug cost: $12,962 (USD; Tot_Drug_Cst)2022 Drug cost: $11,673 (USD; Tot_Drug_Cst)2023 Drug cost: $104,541 (USD; Tot_Drug_Cst)2024 Drug cost: $462,926 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R16$2,203
20211973$12,962
202261109$11,673
2023309815$104,541
20244521,199$462,926

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system120120$93
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more115126$89
92014Established patient complete exam of visual system286291$75
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more201277$63
92134Imaging of retina103140$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine875,100$105,483
CyclosporineCyclosporine422,220$18,003
RhopressaNetarsudil Mesylate15808$6,677
Prednisolone AcetatePrednisolone Acetate1864,772$5,805
FluorometholoneFluorometholone641,378$4,078

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$399Glaukos Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Andrew John Sumnicht, MD?

Tedicare shows public-source Medicare data for Andrew John Sumnicht, MD (NPI 1306335435), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew John Sumnicht, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew John Sumnicht, MD?

Andrew John Sumnicht, MD is linked to NORTH CASCADE EYE ASSOCIATES PS (billing NPI 1093750481) in the available physician profile data.

Does Andrew John Sumnicht, MD have Open Payments data?

Andrew John Sumnicht, MD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.